APYX (STOCKS)
Apyx Medical Corporation Common Stock
$3.880000
-0.080000 (-2.02%)
Prev close: $3.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Charles D. Goodwin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $162.72M
- Employees
- 220
- P/E (TTM)
- -14.15
- P/B (TTM)
- 11.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.03 | $-0.06 | +0.0284 | +48.63% |
|
Sep 2025 (Q3)
|
$-0.05 | $-0.10 | +0.0546 | +52.20% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.10 | +0.0052 | +5.46% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.12 | +0.0224 | +18.30% |
Financial Statements
| Revenues | $52.84M |
| Benefits Costs and Expenses | $63.68M |
| Cost Of Revenue | $19.80M |
| Costs And Expenses | $63.68M |
| Gross Profit | $33.04M |
| Nonoperating Income/Loss | -$4.39M |
| Operating Expenses | $39.49M |
| Selling, General, and Administrative Expenses | $15.80M |
| Research and Development | $3.37M |
| Other Operating Expenses | $20.31M |
| Operating Income/Loss | -$6.45M |
| Income/Loss From Continuing Operations After Tax | -$11.11M |
| Income/Loss From Continuing Operations Before Tax | -$10.84M |
| Income Tax Expense/Benefit | $270.00K |
| Income Tax Expense/Benefit, Current | $270.00K |
| Net Income/Loss | -$11.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $106.00K |
| Net Income/Loss Attributable To Parent | -$11.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.27 |
| Basic Average Shares | 41,095,000 |
| Assets | $66.84M |
| Current Assets | $58.47M |
| Inventory | $8.60M |
| Other Current Assets | $49.87M |
| Noncurrent Assets | $8.37M |
| Fixed Assets | $2.37M |
| Other Non-current Assets | $6.00M |
| Liabilities | $52.01M |
| Current Liabilities | $11.70M |
| Accounts Payable | $3.06M |
| Other Current Liabilities | $8.64M |
| Noncurrent Liabilities | $40.31M |
| Long-term Debt | $37.50M |
| Other Non-current Liabilities | $2.81M |
| Equity | $14.83M |
| Equity Attributable To Noncontrolling Interest | $291.00K |
| Equity Attributable To Parent | $14.54M |
| Liabilities And Equity | $66.84M |
| Net Cash Flow From Operating Activities | -$8.00M |
| Net Cash Flow From Operating Activities, Continuing | -$8.00M |
| Net Cash Flow From Investing Activities | -$1.11M |
| Net Cash Flow From Investing Activities, Continuing | -$1.11M |
| Net Cash Flow From Financing Activities | $9.58M |
| Net Cash Flow From Financing Activities, Continuing | $9.58M |
| Net Cash Flow | $465.00K |
| Net Cash Flow, Continuing | $465.00K |
| Comprehensive Income/Loss | -$11.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.11M |
| Other Comprehensive Income/Loss | $0.00 |